Last updated: May 10, 2026
What is DRAXIMAGE DTPA and who makes it?
DRAXIMAGE DTPA is a radiopharmaceutical drug product used for imaging (commonly referenced for kidney-related nuclear imaging). The key supplier in the supply chain is the registered manufacturer of the finished drug product (labeled as “DRAXIMAGE DTPA” under the specific NDA/label).
The complete, citable supplier set for DRAXIMAGE DTPA (finished product manufacturer, labeled packager, and authorized distributor list by jurisdiction) is not available in the provided information. Under the constraints, no partial sourcing can be produced.
Which suppliers are involved across the value chain?
A radiopharmaceutical supply chain typically separates into two supplier categories:
- Finished drug product manufacturer (MP, NDA/ANDA holder operations)
- Manufactures or controls the final sterile formulation and labeling of “DRAXIMAGE DTPA.”
- Component and raw-material suppliers
- Supply chelator precursor (DTPA) and other pharmaceutical-grade inputs used to manufacture the sterile radiopharmaceutical.
No specific supplier identities, facilities, or contractual partners are provided for DRAXIMAGE DTPA in the input context, so a supplier roster cannot be stated as facts.
What supplier list details are required for patent-grade diligence?
Supplier lists used for investment and R&D due diligence typically require, at minimum, the following:
- Labeling entities: NDA holder / manufacturer / packager of record on the carton and label
- Manufacturing site(s): named facility and country
- Regulatory listings: FDA “Orange Book” or drug establishment registrations tying the label product to sites
- Distribution network: authorized distributors by market and channel
None of these are included in the request context.
Key Takeaways
- DRAXIMAGE DTPA supplier identification requires label- and regulatory-grade source data (manufacturer of record, packager, and site-specific listings).
- No citable supplier information is present in the provided input, so a factual supplier list for DRAXIMAGE DTPA cannot be produced.
FAQs
-
Is DRAXIMAGE DTPA a brand name or a generic radiopharmaceutical?
It is a labeled brand for a DTPA-based radiopharmaceutical product.
-
Who is typically the “supplier” for a radiopharmaceutical like DRAXIMAGE DTPA?
The supplier is usually the finished drug product manufacturer of record on the labeled product.
-
Do component suppliers (DTPA and sterile formulation inputs) count as suppliers?
Yes for supply-chain mapping, but identities must be confirmed from regulatory or labeling records.
-
Can the supplier list vary by country or distributor?
Yes; distribution and sometimes labeling entities can differ by market.
-
What documents best identify the supplier?
Labeling (carton and package insert) and regulatory manufacturing-site listings (for the product and label entity).
References
[1]
